info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > Stem Cells > JAK > Mubritinib (TAK 165)
Mubritinib (TAK 165)  
Catalog No. T6124    CAS 366017-09-6
Pack Size
Availability
Price/USD
Quantity
10mg
In Stock
43.00
50mg
In Stock
169.00
100mg
In Stock
299.00
10mM * 1mL (in DMSO)
In Stock
48.00
25mg
In Stock
102.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:98.00% COA Datasheet
Biological Activity:

Product Description:

Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activity to EGFR, FGFR, PDGFR, JAK1, Src and Blk. Phase 1.

Target:
PDGFR; JAK1; HER2/ErbB2; FGFR; EGFR;
Research Area:
Cancer
Chemical Information:
Molecular Weight 468.47
Formula C25H23F3N4O2
CAS Number 366017-09-6
Solubility DMSO: 13mg/ml(27.75 mM);Water: <1mg/ml;Ethanol: <1mg/ml
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Product Recommendations
  • 4-Oxofenretinide, 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arre...
  • Gemcitabine monophosphate, Gemcitabine monophosphate disodium salt, also called GemMP, is a monophosphate derivative of Gemcita...
  • Repertaxin, Reparixin is a potent inhibitor of both CXCL8 receptors?CXCR1/2, it inhibits weakly?CXCR2-mediated c...
  • Goserelin acetate,

    Goserelin (ICI 118630) acetate is an injectable gonadotropin releasing hormone superagonist (GnRH...

  • AS-8351, AS-8351 is a histone demethylase inhibitor. It has been used in combination with CHIR99021, A 83-01,...

 

Reference

If you have additional questions, Please send us a message. * Required